Your browser doesn't support javascript.
loading
[Efficacy and safety of PD-1 inhibitor combined with chemotherapy in the primary treatment of phase Ⅲ/Ⅳ extranodal nasal-type natural killer/T cell lymphoma].
Liu, Y B; Yuan, X L; Ma, R J; Jiang, L; Wang, L F; Zhu, Z M.
  • Liu YB; Department of Hematology, People's Hospital of Zhengzhou University, Institute of Hematology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
  • Yuan XL; Department of Hematology, People's Hospital of Zhengzhou University, Institute of Hematology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
  • Ma RJ; Department of Hematology, People's Hospital of Zhengzhou University, Institute of Hematology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
  • Jiang L; Department of Hematology, People's Hospital of Zhengzhou University, Institute of Hematology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
  • Wang LF; Department of Pathology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Zhu ZM; Department of Hematology, People's Hospital of Zhengzhou University, Institute of Hematology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
Zhonghua Yi Xue Za Zhi ; 101(16): 1178-1181, 2021 Apr 27.
Article en Zh | MEDLINE | ID: mdl-33902250
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Extranodal de Células NK-T Tipo de estudio: Observational_studies Límite: Humans Idioma: Zh Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Extranodal de Células NK-T Tipo de estudio: Observational_studies Límite: Humans Idioma: Zh Año: 2021 Tipo del documento: Article